Pfizer to ask FDA for emergency use of COVID-19 vaccine
Pfizer and its German partner BioNTech said they will ask the Food and Drug Administration on Friday to allow emergency use of its experimental COVID-19 vaccine, adding that people at high risk for exposure to the disease or most vulnerable to it could start getting shots “by the middle to the end of December.”
The partners are the first drug makers to seek “emergency use authorization” for a vaccine to help end the pandemic that has killed more than 1.3 million people globally, including over 250,000 Americans.
Read the full story on BostonGlobe.com.
|
|
|
|
|
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list.
|
|
|
|
